Strattera (atomoxetine)

ApprovedCompleted
0 watching 0 views this week๐Ÿ”ฅ Hot
85
Hype Score

Development Stage

โœ“
Pre-clinical
โœ“
Phase 1
โœ“
Phase 2
โœ“
Phase 3
5
Approved
Indication / Disease

ADHD NOS

Conditions

ADHD NOS

Trial Timeline

Dec 1, 2003 โ†’ Jul 1, 2008

About Strattera (atomoxetine)

Strattera (atomoxetine) is a approved stage product being developed by Eli Lilly for ADHD NOS. The current trial status is completed. This product is registered under clinical trial identifier NCT00181766. Target conditions include ADHD NOS.

Hype Score Breakdown

Clinical
30
Activity
20
Company
10
Novelty
10
Community
12

Clinical Trials (1)

NCT IDPhaseStatus
NCT00181766ApprovedCompleted

Competing Products

20 competing products in ADHD NOS

See all competitors